Premium
Ivermectin: pharmacology and application in dermatology
Author(s) -
Dourmishev Assen L.,
Dourmishev Lyubomir A.,
Schwartz Robert A.
Publication year - 2005
Publication title -
international journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 93
eISSN - 1365-4632
pISSN - 0011-9059
DOI - 10.1111/j.1365-4632.2004.02253.x
Subject(s) - ivermectin , scabies , cutaneous larva migrans , myiasis , dermatology , medicine , sarcoptes scabiei , onchocerciasis , filariasis , strongyloides stercoralis , onchocerca volvulus , antiparasitic agent , biology , helminthiasis , veterinary medicine , helminths , immunology , larva , larva migrans , botany
Ivermectin is a synthetic derivative of the antiparasitic class of compounds known as avermectins. It is a macrolide endectocide with activity against both endoparasites with cutaneous tropism ( Strongyloides stercoralis , Ancylostoma braziliense , Cochliomyia hominivorax , Dermatobia hominis , Filaria bancrofti , Wucheria malayi , Onchocerca volvulus , Loa‐loa ) and ectoparasites such as Sarcoptes scabies , Pediculus humanus , Demodex folliculorum , and Cheyletiella sp. Ivermectin is of great interest in the treatment of patients with different forms of scabies, head lice, demodecidosis, cutaneous larva migrans, cutaneous larva currens, myiasis, and filariasis.